Veru Inc. stock is up 32.33% since 30 days ago. The next earnings date is Feb 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 56% of the previous 25 February’s closed higher than January. 100% of analysts rate it a buy.
Veru Inc. focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial partners. The company was formerly known as The Female Health Company.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!